{"transactions":[{"id":700615,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27748,"kind":"organization","name":"RTW Fund Group GP, LLC","position":1,"cik":"0002147397","reported_name":"RTW Fund Group GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":27749,"kind":"person","name":"WONG RODERICK","position":2,"cik":"0001493280","reported_name":"WONG RODERICK","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants (Right to Buy)","published_at":"2026-07-30T20:05:03.000Z","date":"2026-07-29","kind":"other","planned":false,"acquired":true,"shares":133290,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of that certain Exchange Agreement, dated as of July 29, 2026, RTW Entity (as defined below) exchanged 133,290 shares of the Issuer's common\nstock for pre-funded warrants to purchase an equivalent number of shares of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The pre-funded warrants to purchase shares of the Issuer's common stock (the \"Pre-Funded Warrants\") have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The pre-funded warrants to purchase shares of the Issuer's common stock (the \"Pre-Funded Warrants\") have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by a certain affiliated entity (\"RTW Entity\") managed by RTW Fund Group GP, LLC (\"RTW Fund Group\"). Roderick Wong, M.D. serves as the Managing Member of RTW Fund Group. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein."}],"balance_after":8949719,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":133290},"source":{"system":"sec-edgar","filing":"0001104659-26-088665","document":"tm2621459-14_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493280/000110465926088665/tm2621459-14_4seq1.xml","form_type":"4"}},{"id":700614,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27748,"kind":"organization","name":"RTW Fund Group GP, LLC","position":1,"cik":"0002147397","reported_name":"RTW Fund Group GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":27749,"kind":"person","name":"WONG RODERICK","position":2,"cik":"0001493280","reported_name":"WONG RODERICK","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-30T20:05:03.000Z","date":"2026-07-29","kind":"other","planned":false,"acquired":false,"shares":133290,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of that certain Exchange Agreement, dated as of July 29, 2026, RTW Entity (as defined below) exchanged 133,290 shares of the Issuer's common\nstock for pre-funded warrants to purchase an equivalent number of shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by a certain affiliated entity (\"RTW Entity\") managed by RTW Fund Group GP, LLC (\"RTW Fund Group\"). Roderick Wong, M.D. serves as the Managing Member of RTW Fund Group. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein."}],"balance_after":266307,"source":{"system":"sec-edgar","filing":"0001104659-26-088665","document":"tm2621459-14_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493280/000110465926088665/tm2621459-14_4seq1.xml","form_type":"4"}},{"id":701343,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27989,"kind":"person","name":"Ashiya Mona","position":1,"cik":"0001794070","reported_name":"Ashiya Mona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-30T01:36:56.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":15435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase 15,435 shares of the Issuer's common stock, which vests in full on the earlier of (i) July 27, 2027 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the recipient's continued service to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Pursuant to an agreement with OrbiMed Advisors LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments X, LP."}],"balance_after":15435,"derivative":{"exercise_price":28.56,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":15435},"source":{"system":"sec-edgar","filing":"0001104659-26-088371","document":"tm2621459-11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926088371/tm2621459-11_4seq1.xml","form_type":"4"}},{"id":701341,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-30T01:33:55.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":185798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase 185,798 shares of the Issuer's common stock, one quarter of which will vest on July 27, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":185798,"derivative":{"exercise_price":28.56,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":185798},"source":{"system":"sec-edgar","filing":"0001104659-26-088370","document":"tm2621459-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926088370/tm2621459-10_4seq1.xml","form_type":"4"}},{"id":703376,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-24T21:00:10.000Z","date":"2026-07-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":22516,"price":0.8976,"value":20210.3616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":74918,"source":{"system":"sec-edgar","filing":"0001867033-26-000008","document":"form4-07242026_050707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000186703326000008/form4-07242026_050707.xml","form_type":"4"}},{"id":703373,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-07-24T21:00:08.000Z","date":"2026-07-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":15405,"price":0.8976,"value":13827.528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":95944,"source":{"system":"sec-edgar","filing":"0001727756-26-000008","document":"form4-07242026_050705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172775626000008/form4-07242026_050705.xml","form_type":"4"}},{"id":703372,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2026-07-24T21:00:07.000Z","date":"2026-07-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":22516,"price":0.8976,"value":20210.3616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":95918,"source":{"system":"sec-edgar","filing":"0001727809-26-000008","document":"form4-07242026_050703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172780926000008/form4-07242026_050703.xml","form_type":"4"}},{"id":703371,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2026-07-24T21:00:05.000Z","date":"2026-07-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":79391,"price":0.8976,"value":71261.3616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":347174,"source":{"system":"sec-edgar","filing":"0001727794-26-000010","document":"form4-07242026_050701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172779426000010/form4-07242026_050701.xml","form_type":"4"}},{"id":717264,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-03T00:05:09.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3464,"price":0.6507,"value":2254.0248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":97434,"source":{"system":"sec-edgar","filing":"0001867033-26-000006","document":"form4-07022026_080706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000186703326000006/form4-07022026_080706.xml","form_type":"4"}},{"id":717263,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-07-03T00:05:08.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2370,"price":0.6507,"value":1542.159,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":111349,"source":{"system":"sec-edgar","filing":"0001727756-26-000006","document":"form4-07022026_080704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172775626000006/form4-07022026_080704.xml","form_type":"4"}},{"id":717262,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2026-07-03T00:05:06.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3464,"price":0.6507,"value":2254.0248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":118434,"source":{"system":"sec-edgar","filing":"0001727809-26-000006","document":"form4-07022026_080702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172780926000006/form4-07022026_080702.xml","form_type":"4"}},{"id":717261,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2026-07-03T00:05:04.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":12214,"price":0.6507,"value":7947.6498,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":426565,"source":{"system":"sec-edgar","filing":"0001727794-26-000008","document":"form4-07022026_080701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172779426000008/form4-07022026_080701.xml","form_type":"4"}},{"id":754110,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2026-06-02T21:00:11.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":30791,"price":0.31,"value":9545.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2025 and ending on May 31, 2026 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on December 1, 2025 (the first trading day of the offering period). The Reporting Person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year."}],"balance_after":438779,"source":{"system":"sec-edgar","filing":"0001727794-26-000006","document":"form4-06022026_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172779426000006/form4-06022026_050601.xml","form_type":"4"}},{"id":818991,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-02T20:15:23.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4007,"price":0.5975,"value":2394.1825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":99788,"source":{"system":"sec-edgar","filing":"0001867033-26-000004","document":"form4-04022026_040408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000186703326000004/form4-04022026_040408.xml","form_type":"4"}},{"id":818990,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-04-02T20:15:19.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2876,"price":0.5975,"value":1718.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":112363,"source":{"system":"sec-edgar","filing":"0001727756-26-000004","document":"form4-04022026_040407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172775626000004/form4-04022026_040407.xml","form_type":"4"}},{"id":818989,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2026-04-02T20:15:14.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4007,"price":0.5975,"value":2394.1825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":121898,"source":{"system":"sec-edgar","filing":"0001727809-26-000004","document":"form4-04022026_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172780926000004/form4-04022026_040405.xml","form_type":"4"}},{"id":818988,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2026-04-02T20:15:11.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14232,"price":0.5975,"value":8503.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":401976,"source":{"system":"sec-edgar","filing":"0001727794-26-000004","document":"form4-04022026_040403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172779426000004/form4-04022026_040403.xml","form_type":"4"}},{"id":950215,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2026-01-05T13:30:40.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":12684,"price":0.5801,"value":7357.9884,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":416208,"source":{"system":"sec-edgar","filing":"0001727794-26-000002","document":"form4-01052026_010137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172779426000002/form4-01052026_010137.xml","form_type":"4"}},{"id":950214,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-05T13:30:09.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":7858,"price":0.5801,"value":4558.4258,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":103795,"source":{"system":"sec-edgar","filing":"0001867033-26-000002","document":"form4-01052026_080105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000186703326000002/form4-01052026_080105.xml","form_type":"4"}},{"id":950213,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-01-05T13:30:07.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2448,"price":0.5801,"value":1420.0848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":115239,"source":{"system":"sec-edgar","filing":"0001727756-26-000002","document":"form4-01052026_080104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172775626000002/form4-01052026_080104.xml","form_type":"4"}},{"id":950212,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2026-01-05T13:30:05.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":3579,"price":0.5801,"value":2076.1779,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":125905,"source":{"system":"sec-edgar","filing":"0001727809-26-000002","document":"form4-01052026_080101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172780926000002/form4-01052026_080101.xml","form_type":"4"}},{"id":968855,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":39568,"kind":"person","name":"Little Elisabeth Sandoval","position":1,"cik":"0001632295","reported_name":"Little Elisabeth Sandoval","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-15T21:15:11.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2026, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":0.3756,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001632295-25-000005","document":"form4-12152025_041207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000163229525000005/form4-12152025_041207.xml","form_type":"4"}},{"id":969979,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-15T16:15:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2026, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":0.3756,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001055404-25-000004","document":"form4-12152025_041205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000105540425000004/form4-12152025_041205.xml","form_type":"4"}},{"id":969240,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-15T16:15:08.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2026, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":0.3756,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001417397-25-000004","document":"form4-12152025_041203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000141739725000004/form4-12152025_041203.xml","form_type":"4"}},{"id":969182,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-15T16:15:06.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2026, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":0.3756,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001240499-25-000004","document":"form4-12152025_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000124049925000004/form4-12152025_041201.xml","form_type":"4"}},{"id":1026542,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-02T21:05:10.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3420,"price":0.335,"value":1145.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":111653,"source":{"system":"sec-edgar","filing":"0001867033-25-000003","document":"form4-10022025_051007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000186703325000003/form4-10022025_051007.xml","form_type":"4"}},{"id":1026540,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-10-02T21:05:09.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2453,"price":0.335,"value":821.755,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":117687,"source":{"system":"sec-edgar","filing":"0001727756-25-000003","document":"form4-10022025_051005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172775625000003/form4-10022025_051005.xml","form_type":"4"}},{"id":1026539,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2025-10-02T21:05:08.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3581,"price":0.335,"value":1199.635,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":129484,"source":{"system":"sec-edgar","filing":"0001727809-25-000003","document":"form4-10022025_051003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172780925000003/form4-10022025_051003.xml","form_type":"4"}},{"id":1026538,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-10-02T21:05:05.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":12676,"price":0.335,"value":4246.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":428892,"source":{"system":"sec-edgar","filing":"0001727794-25-000003","document":"form4-10022025_051001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000172779425000003/form4-10022025_051001.xml","form_type":"4"}},{"id":1094335,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-02T20:30:48.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3420,"price":1.65,"value":5643.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":115073,"source":{"system":"sec-edgar","filing":"0001415889-25-019059","document":"form4-07022025_040710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925019059/form4-07022025_040710.xml","form_type":"4"}},{"id":1094334,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-07-02T20:30:42.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2453,"price":1.65,"value":4047.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":120140,"source":{"system":"sec-edgar","filing":"0001415889-25-019058","document":"form4-07022025_040708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925019058/form4-07022025_040708.xml","form_type":"4"}},{"id":1094333,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2025-07-02T20:30:38.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3581,"price":1.65,"value":5908.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":133065,"source":{"system":"sec-edgar","filing":"0001415889-25-019057","document":"form4-07022025_040706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925019057/form4-07022025_040706.xml","form_type":"4"}},{"id":1094332,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-07-02T20:30:22.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":12676,"price":1.65,"value":20915.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":441568,"source":{"system":"sec-edgar","filing":"0001415889-25-019056","document":"form4-07022025_040705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925019056/form4-07022025_040705.xml","form_type":"4"}},{"id":1124275,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2025-06-03T20:15:07.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":1145,"price":0.81,"value":927.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2024 and ending on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 30, 2025 (the last trading day of the offering period)."}],"balance_after":136646,"source":{"system":"sec-edgar","filing":"0001415889-25-015383","document":"form4-06032025_040603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925015383/form4-06032025_040603.xml","form_type":"4"}},{"id":1124274,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-06-03T20:15:04.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":8681,"price":0.81,"value":7031.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2024 and ending on May 31, 2025 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 30, 2025 (the last trading day of the offering period). The Reporting Person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year."}],"balance_after":454244,"source":{"system":"sec-edgar","filing":"0001415889-25-015382","document":"form4-06032025_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925015382/form4-06032025_040601.xml","form_type":"4"}},{"id":1182659,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-02T20:15:24.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":8399,"price":1.58,"value":13270.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":118493,"source":{"system":"sec-edgar","filing":"0001415889-25-009633","document":"form4-04022025_040416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925009633/form4-04022025_040416.xml","form_type":"4"}},{"id":1182658,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-04-02T20:15:20.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":6044,"price":1.58,"value":9549.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":122593,"source":{"system":"sec-edgar","filing":"0001415889-25-009632","document":"form4-04022025_040413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925009632/form4-04022025_040413.xml","form_type":"4"}},{"id":1182657,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2025-04-02T20:15:17.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":8828,"price":1.58,"value":13948.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":135501,"source":{"system":"sec-edgar","filing":"0001415889-25-009631","document":"form4-04022025_040410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925009631/form4-04022025_040410.xml","form_type":"4"}},{"id":1182641,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-04-02T20:15:11.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":30498,"price":1.58,"value":48186.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":445563,"source":{"system":"sec-edgar","filing":"0001415889-25-009629","document":"form4-04022025_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925009629/form4-04022025_040405.xml","form_type":"4"}},{"id":1296217,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T21:15:13.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2026 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":230000,"derivative":{"exercise_price":2.77,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001415889-25-001927","document":"form4-01232025_040109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925001927/form4-01232025_040109.xml","form_type":"4"}},{"id":1296213,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T21:15:12.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2026 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":230000,"derivative":{"exercise_price":2.77,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001415889-25-001926","document":"form4-01232025_040106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925001926/form4-01232025_040106.xml","form_type":"4"}},{"id":1296212,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T21:15:08.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2026 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":230000,"derivative":{"exercise_price":2.77,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001415889-25-001924","document":"form4-01232025_040104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925001924/form4-01232025_040104.xml","form_type":"4"}},{"id":1296211,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T21:15:05.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":730000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2026 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":730000,"derivative":{"exercise_price":2.77,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":730000},"source":{"system":"sec-edgar","filing":"0001415889-25-001923","document":"form4-01232025_040101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925001923/form4-01232025_040101.xml","form_type":"4"}},{"id":1301736,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-16T18:06:19.000Z","date":"2025-01-15","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":2.92,"value":43800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $2.8776 to $2.9836, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":51472,"source":{"system":"sec-edgar","filing":"0001415889-25-001574","document":"form4-01162025_110115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000141588925001574/form4-01162025_110115.xml","form_type":"4"}},{"id":1318315,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-02T22:45:11.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4675,"price":3.35,"value":15661.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":126892,"source":{"system":"sec-edgar","filing":"0001415889-25-000156","document":"form4-01022025_050107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925000156/form4-01022025_050107.xml","form_type":"4"}},{"id":1318314,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-01-02T22:45:10.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4857,"price":3.35,"value":16270.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":128637,"source":{"system":"sec-edgar","filing":"0001415889-25-000155","document":"form4-01022025_050105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925000155/form4-01022025_050105.xml","form_type":"4"}},{"id":1318313,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2025-01-02T22:45:07.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4697,"price":3.35,"value":15734.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":144329,"source":{"system":"sec-edgar","filing":"0001415889-25-000154","document":"form4-01022025_050103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925000154/form4-01022025_050103.xml","form_type":"4"}},{"id":1318312,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-01-02T22:45:04.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":24536,"price":3.35,"value":82195.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":476061,"source":{"system":"sec-edgar","filing":"0001415889-25-000152","document":"form4-01022025_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925000152/form4-01022025_050101.xml","form_type":"4"}},{"id":1331957,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":85070,"kind":"person","name":"Borowski Christine","position":1,"cik":"0002005073","reported_name":"Borowski Christine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-13T21:15:33.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.4,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-029291","document":"form4-12132024_041217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924029291/form4-12132024_041217.xml","form_type":"4"}},{"id":1331956,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":39568,"kind":"person","name":"Little Elisabeth Sandoval","position":1,"cik":"0001632295","reported_name":"Sandoval Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-13T21:15:17.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.4,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-029287","document":"form4-12132024_041209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924029287/form4-12132024_041209.xml","form_type":"4"}},{"id":1332967,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-13T16:15:29.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.4,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-029290","document":"form4-12132024_041215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000141588924029290/form4-12132024_041215.xml","form_type":"4"}},{"id":1332196,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-13T16:15:26.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.4,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-029288","document":"form4-12132024_041211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000141588924029288/form4-12132024_041211.xml","form_type":"4"}},{"id":1332134,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-13T16:15:20.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.4,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-029289","document":"form4-12132024_041213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000141588924029289/form4-12132024_041213.xml","form_type":"4"}},{"id":1332181,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":85082,"kind":"person","name":"Bruno Anthony D","position":1,"cik":"0001374180","reported_name":"Bruno Anthony D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-13T16:15:14.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.4,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-029286","document":"form4-12132024_041207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374180/000141588924029286/form4-12132024_041207.xml","form_type":"4"}},{"id":1344461,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-03T21:15:06.000Z","date":"2024-11-30","kind":"grant","planned":false,"acquired":true,"shares":3901,"price":2.1,"value":8192.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on June 1, 2024 and ending on November 30, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on June 3, 2024 (the first trading day of the offering period). The Reporting Person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year."}],"balance_after":500597,"source":{"system":"sec-edgar","filing":"0001415889-24-028073","document":"form4-12032024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924028073/form4-12032024_041201.xml","form_type":"4"}},{"id":1393749,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-02T20:15:16.000Z","date":"2024-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":84,"price":1.88,"value":157.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":131567,"source":{"system":"sec-edgar","filing":"0001415889-24-024383","document":"form4-10022024_041008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924024383/form4-10022024_041008.xml","form_type":"4"}},{"id":1393748,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-10-02T20:15:11.000Z","date":"2024-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":109,"price":1.88,"value":204.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":133494,"source":{"system":"sec-edgar","filing":"0001415889-24-024382","document":"form4-10022024_041005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924024382/form4-10022024_041005.xml","form_type":"4"}},{"id":1393747,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-10-02T20:15:08.000Z","date":"2024-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":685,"price":1.88,"value":1287.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock\nunits."}],"balance_after":496696,"source":{"system":"sec-edgar","filing":"0001415889-24-024380","document":"form4-10022024_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924024380/form4-10022024_041001.xml","form_type":"4"}},{"id":1393746,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2024-10-02T20:15:07.000Z","date":"2024-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":105,"price":1.88,"value":197.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":149026,"source":{"system":"sec-edgar","filing":"0001415889-24-024381","document":"form4-10022024_041004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924024381/form4-10022024_041004.xml","form_type":"4"}},{"id":1459351,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-03T20:15:18.000Z","date":"2024-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":92,"price":1.92,"value":176.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":131651,"source":{"system":"sec-edgar","filing":"0001415889-24-019176","document":"form4-07032024_040715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924019176/form4-07032024_040715.xml","form_type":"4"}},{"id":1459350,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-07-03T20:15:16.000Z","date":"2024-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":138,"price":1.92,"value":264.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":133603,"source":{"system":"sec-edgar","filing":"0001415889-24-019175","document":"form4-07032024_040713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924019175/form4-07032024_040713.xml","form_type":"4"}},{"id":1459349,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2024-07-03T20:15:15.000Z","date":"2024-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":143,"price":1.92,"value":274.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":149131,"source":{"system":"sec-edgar","filing":"0001415889-24-019174","document":"form4-07032024_040711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924019174/form4-07032024_040711.xml","form_type":"4"}},{"id":1459348,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-07-03T20:15:12.000Z","date":"2024-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":935,"price":1.92,"value":1795.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock\nunits."}],"balance_after":497654,"source":{"system":"sec-edgar","filing":"0001415889-24-019173","document":"form4-07032024_040709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924019173/form4-07032024_040709.xml","form_type":"4"}},{"id":1491453,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-06-04T20:30:24.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":4429,"price":2.159,"value":9562.211,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2023 and ending on May 31, 2024 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 31, 2024."}],"balance_after":498589,"source":{"system":"sec-edgar","filing":"0001415889-24-015370","document":"form4-06042024_040620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924015370/form4-06042024_040620.xml","form_type":"4"}},{"id":1548658,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-03T21:08:01.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":94,"price":3.08,"value":289.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":131743,"source":{"system":"sec-edgar","filing":"0001415889-24-010074","document":"form4-04032024_090450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924010074/form4-04032024_090450.xml","form_type":"4"}},{"id":1548657,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-04-03T21:06:20.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":157,"price":3.08,"value":483.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":133741,"source":{"system":"sec-edgar","filing":"0001415889-24-010070","document":"form4-04032024_090410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924010070/form4-04032024_090410.xml","form_type":"4"}},{"id":1548656,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER AND GC"}}],"security":"Common Stock","published_at":"2024-04-03T21:04:34.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":161,"price":3.08,"value":495.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":149274,"source":{"system":"sec-edgar","filing":"0001415889-24-010067","document":"form4-04032024_090429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924010067/form4-04032024_090429.xml","form_type":"4"}},{"id":1548655,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-04-03T21:02:56.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1004,"price":3.08,"value":3092.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock\nunits."}],"balance_after":494160,"source":{"system":"sec-edgar","filing":"0001415889-24-010064","document":"form4-04032024_090445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924010064/form4-04032024_090445.xml","form_type":"4"}},{"id":1691028,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T22:22:05.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-24-000470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000470/doc4.xml","form_type":"4"}},{"id":1691027,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T22:22:05.000Z","date":"2024-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":93,"price":2.28,"value":212.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":131837,"source":{"system":"sec-edgar","filing":"0001209191-24-000470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000470/doc4.xml","form_type":"4"}},{"id":1691026,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T22:22:05.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":131930,"source":{"system":"sec-edgar","filing":"0001209191-24-000470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000470/doc4.xml","form_type":"4"}},{"id":1691025,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T22:21:06.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-24-000469","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000469/doc4.xml","form_type":"4"}},{"id":1691024,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-01-03T22:21:06.000Z","date":"2024-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":157,"price":2.28,"value":357.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":133898,"source":{"system":"sec-edgar","filing":"0001209191-24-000469","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000469/doc4.xml","form_type":"4"}},{"id":1691023,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-01-03T22:21:06.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":134055,"source":{"system":"sec-edgar","filing":"0001209191-24-000469","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000469/doc4.xml","form_type":"4"}},{"id":1691022,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer and GC"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T22:20:02.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-24-000467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000467/doc4.xml","form_type":"4"}},{"id":1691021,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer and GC"}}],"security":"Common Stock","published_at":"2024-01-03T22:20:02.000Z","date":"2024-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":161,"price":2.28,"value":367.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":149435,"source":{"system":"sec-edgar","filing":"0001209191-24-000467","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000467/doc4.xml","form_type":"4"}},{"id":1691020,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer and GC"}}],"security":"Common Stock","published_at":"2024-01-03T22:20:02.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":149596,"source":{"system":"sec-edgar","filing":"0001209191-24-000467","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000467/doc4.xml","form_type":"4"}},{"id":1691019,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T22:17:25.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":225000,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-24-000465","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000465/doc4.xml","form_type":"4"}},{"id":1691018,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-03T22:17:25.000Z","date":"2024-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1004,"price":2.28,"value":2289.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":495164,"source":{"system":"sec-edgar","filing":"0001209191-24-000465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000465/doc4.xml","form_type":"4"}},{"id":1691017,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-03T22:17:25.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":496168,"source":{"system":"sec-edgar","filing":"0001209191-24-000465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000465/doc4.xml","form_type":"4"}},{"id":1691016,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":39568,"kind":"person","name":"Little Elisabeth Sandoval","position":1,"cik":"0001632295","reported_name":"Sandoval Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T22:14:22.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-24-000463","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000463/doc4.xml","form_type":"4"}},{"id":1691015,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":85070,"kind":"person","name":"Borowski Christine","position":1,"cik":"0002005073","reported_name":"Borowski Christine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T22:07:13.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable as to 1/3rd of the shares subject to the option on each annual anniversary of the date of grant, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-24-000456","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000456/doc4.xml","form_type":"4"}},{"id":1693854,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T17:13:09.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-24-000462","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919124000462/doc4.xml","form_type":"4"}},{"id":1691694,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":85082,"kind":"person","name":"Bruno Anthony D","position":1,"cik":"0001374180","reported_name":"Bruno Anthony D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T17:11:50.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-24-000461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374180/000120919124000461/doc4.xml","form_type":"4"}},{"id":1691869,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T17:10:38.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-24-000460","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000120919124000460/doc4.xml","form_type":"4"}},{"id":1691539,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T17:09:19.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-24-000459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919124000459/doc4.xml","form_type":"4"}},{"id":1708793,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T22:11:27.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-23-058819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123058819/doc4.xml","form_type":"4"}},{"id":1708792,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-15T22:11:27.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":69430,"source":{"system":"sec-edgar","filing":"0001209191-23-058819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123058819/doc4.xml","form_type":"4"}},{"id":1708791,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T22:10:21.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-23-058818","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123058818/doc4.xml","form_type":"4"}},{"id":1708790,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28717,"kind":"person","name":"Stuart Iain","position":1,"cik":"0001727756","reported_name":"Stuart Iain","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-12-15T22:10:21.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":71555,"source":{"system":"sec-edgar","filing":"0001209191-23-058818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123058818/doc4.xml","form_type":"4"}},{"id":1708789,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer and GC"}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T22:09:13.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-23-058817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123058817/doc4.xml","form_type":"4"}},{"id":1708788,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28716,"kind":"person","name":"Harsch Mutya","position":1,"cik":"0001727809","reported_name":"Harsch Mutya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer and GC"}}],"security":"Common Stock","published_at":"2023-12-15T22:09:13.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":87096,"source":{"system":"sec-edgar","filing":"0001209191-23-058817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123058817/doc4.xml","form_type":"4"}},{"id":1708787,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T22:08:01.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":225000,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-23-058815","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123058815/doc4.xml","form_type":"4"}},{"id":1708786,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-15T22:08:01.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":271168,"source":{"system":"sec-edgar","filing":"0001209191-23-058815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123058815/doc4.xml","form_type":"4"}},{"id":1708785,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":39568,"kind":"person","name":"Little Elisabeth Sandoval","position":1,"cik":"0001632295","reported_name":"Sandoval Elisabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T22:06:57.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-058813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123058813/doc4.xml","form_type":"4"}},{"id":1709762,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71594,"kind":"person","name":"LEPORE PATRICK G","position":1,"cik":"0001055404","reported_name":"LEPORE PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T17:05:26.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-058812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055404/000120919123058812/doc4.xml","form_type":"4"}},{"id":1709066,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":85082,"kind":"person","name":"Bruno Anthony D","position":1,"cik":"0001374180","reported_name":"Bruno Anthony D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T17:04:11.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-058811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374180/000120919123058811/doc4.xml","form_type":"4"}},{"id":1709080,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":66703,"kind":"person","name":"Basta Steven L","position":1,"cik":"0001417397","reported_name":"Basta Steven L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T17:02:37.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-058809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1417397/000120919123058809/doc4.xml","form_type":"4"}},{"id":1708976,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T17:01:39.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date."}],"balance_after":20000,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-058807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000120919123058807/doc4.xml","form_type":"4"}},{"id":1723474,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":28715,"kind":"person","name":"Domzalski David","position":1,"cik":"0001727794","reported_name":"Domzalski David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-04T21:30:29.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":2284,"price":2.8135,"value":6426.034,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on June 1, 2023 and ending on November 30, 2023 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on November 30, 2023 (the last trading day of the offering period). The reporting person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year."}],"balance_after":46168,"source":{"system":"sec-edgar","filing":"0001209191-23-057220","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123057220/doc4.xml","form_type":"4"}}],"next_cursor":"2023-12-04T21:30:29.000000Z,1723474"}